119 related articles for article (PubMed ID: 12717238)
1. The frequency of interferon-gproducing cells reflects alloreactivity against minor histocompatibility antigens.
van Besouw NM; Vaessen LM; Zuijderwijk JM; van Vliet M; IJzermans JN; van Der Meide PH; Weimar W
Transplantation; 2003 Apr; 75(8):1400-4. PubMed ID: 12717238
[TBL] [Abstract][Full Text] [Related]
2. Donor-reactive cytokine profiles after HLA-identical living-related kidney transplantation.
Gerrits JH; van de Wetering J; Drabbels JJ; Claas FH; Weimar W; van Besouw NM
Nephrol Dial Transplant; 2008 Jun; 23(6):2016-23. PubMed ID: 18156655
[TBL] [Abstract][Full Text] [Related]
3. Non-HLA T-cell reactivity during the first year after HLA-identical living-related kidney transplantation.
Gerrits JH; van de Wetering J; Drabbels JJ; IJzermans JN; Claas FH; Weimar W; van Besouw NM
Clin Transplant; 2009; 23(5):740-7. PubMed ID: 19563488
[TBL] [Abstract][Full Text] [Related]
4. Stable T-cell reactivity after successful tapering of azathioprine in HLA-identical living-related kidney transplant recipients despite minor histocompatibility antigen mismatches.
Gerrits JH; van de Wetering J; Postma S; Drabbels JJ; Vaessen LM; IJzermans JN; Rischen J; Claas FH; Weimar W; van Besouw NM
Nephrol Dial Transplant; 2007 Feb; 22(2):353-61. PubMed ID: 17124279
[TBL] [Abstract][Full Text] [Related]
5. Granzyme B ELISPOT assay determines the cytotoxic T lymphocyte precursor frequency after HLA-identical living-related kidney transplantation.
Gerrits JH; van de Wetering J; Ijzermans JN; Weimar W; van Besouw NM
Transplant Proc; 2005 Mar; 37(2):752-4. PubMed ID: 15848521
[TBL] [Abstract][Full Text] [Related]
6. Deficient TNF-alpha and IFN-gamma production correlates with nondetectable donor-specific cytotoxicity after clinical kidney transplantation.
van Besouw NM; de Kuiper R; van der Mast BJ; van de Wetering J; Baan CC; Weimar W
Transplantation; 2009 May; 87(10):1451-4. PubMed ID: 19461480
[TBL] [Abstract][Full Text] [Related]
7. A multiplex bead array analysis to monitor donor-specific cytokine responses after withdrawal of immunosuppression in HLA-identical living related kidney transplant patients.
Gerrits JH; van de Wetering J; van Beelen E; Claas FH; Weimar W; van Besouw NM
Transplant Proc; 2009 Jun; 41(5):1577-82. PubMed ID: 19545683
[TBL] [Abstract][Full Text] [Related]
8. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.
Vampa ML; Norman PJ; Burnapp L; Vaughan RW; Sacks SH; Wong W
Transplantation; 2003 Oct; 76(8):1220-8. PubMed ID: 14578757
[TBL] [Abstract][Full Text] [Related]
9. Pretransplant donor-specific interferon-gamma ELISPOT assay predicts acute rejection episodes in renal transplant recipients.
Kim SH; Oh EJ; Kim MJ; Park YJ; Han K; Yang HJ; Kim JY; Choi BS; Yang CW; Kim YS; Bang BK
Transplant Proc; 2007 Dec; 39(10):3057-60. PubMed ID: 18089321
[TBL] [Abstract][Full Text] [Related]
10. A novel approach to detect donor/recipent immune responses between HLA-identical pairs.
Jin Y; Hernandez A; Fuller L; Rosen A; Cirocco R; Esquenazi V; Ciancio G; Burke GW; Miller J
Hum Immunol; 2007 May; 68(5):350-61. PubMed ID: 17462502
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between the IFN-gamma producing cells specific for recipient and acute graft versus host disease].
Meng XJ; Lin MF; Cai Z
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):95-8. PubMed ID: 16732961
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of cellular immunity by interferon-gamma enzyme-linked immunosorbent spot assay in kidney allograft recipients: preliminary results of a longitudinal study.
Bellisola G; Tridente G; Nacchia F; Fior F; Boschiero L
Transplant Proc; 2006 May; 38(4):1014-7. PubMed ID: 16757248
[TBL] [Abstract][Full Text] [Related]
13. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
14. Expression of human minor histocompatibility antigen on cultured kidney cells.
Beck Y; Sekimata M; Nakayama S; Müller GA; Müller CA; Yamamoto J; Nagao T; Uchida H; Akiyama N; Kariyone A
Eur J Immunol; 1993 Feb; 23(2):467-72. PubMed ID: 8382163
[TBL] [Abstract][Full Text] [Related]
15. Modified ELISPOT technique--highly significant inverse correlation of post-Tx donor-reactive IFNgamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients.
Näther BJ; Nickel P; Bold G; Presber F; Schönemann C; Pratschke J; Volk HD; Reinke P
Transpl Immunol; 2006 Nov; 16(3-4):232-7. PubMed ID: 17138059
[TBL] [Abstract][Full Text] [Related]
16. HA-1 mismatch has significant effect in chronic allograft nephropathy in clinical renal transplantation.
Krishnan NS; Higgins RM; Lam FT; Kashi H; Jobson S; Ramaiyan K; Rahman M; Morris A
Transplant Proc; 2007 Jun; 39(5):1439-45. PubMed ID: 17580157
[TBL] [Abstract][Full Text] [Related]
17. A model for human leukocyte antigen-matched donor-swap transplantation in India.
Basu G; Daniel D; Rajagopal A; Neelakantan N; John GT
Transplantation; 2008 Mar; 85(5):687-92. PubMed ID: 18337661
[TBL] [Abstract][Full Text] [Related]
18. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes.
Heeger PS; Greenspan NS; Kuhlenschmidt S; Dejelo C; Hricik DE; Schulak JA; Tary-Lehmann M
J Immunol; 1999 Aug; 163(4):2267-75. PubMed ID: 10438971
[TBL] [Abstract][Full Text] [Related]
19. Allograft infiltrating cytotoxic T lymphocytes recognize kidney-specific human minor histocompatibility antigens.
Poindexter N; Shenoy S; Howard T; Flye MW; Mohanakumar T
Clin Transplant; 1997 Jun; 11(3):174-7. PubMed ID: 9193838
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
Matsushita M; Yamazaki R; Ikeda H; Mori T; Sumimoto H; Fujita T; Okamoto S; Ikeda Y; Kawakami Y
Br J Haematol; 2006 Jan; 132(1):56-65. PubMed ID: 16371020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]